Basic Information
Genticel is a French clinical-stage biotechnology company founded by Benedikt Timmerman in 2001, dedicated to developing innovative immunotherapies aimed at treating viral infections and virus-induced diseases. Genticel's goal is to become a leader in immunotherapy for multiple indications, starting with HPV and HPV-induced diseases such as cervical cancer.
Genticel
Paris,Ile-de-France,France
15~50 people
January 01, 2001
--